Introduction
Acute aortic dissection is associated with poor outcomes. 1 Aortic dissection is classified as Stanford Type A when involving the ascending aorta and Type B when involving the descending aorta or arch. 2 Stanford Type A has a well-accepted management algorithm with aggressive control of blood pressure and immediate transfer to a cardiac surgery unit for surgical intervention (American Heart Association Guidelines [AHA] and European Society of Cardiology 3, 4 ). Stanford Type B, however, has been shown to have significantly better outcomes when treated medically (International Registry Aortic Dissection [IRAD] 1 ). As such simple uncomplicated acute Type B aortic dissection within the UK has for decades largely been treated in non-specialized departments with attempts to refer to cardiac services rebuffed. The incidence and prevalence of Type B aortic dissection in the UK is unknown and there has been no systematic collection of data on diagnosis, management or outcomes. These patients are commonly young and they are not served well by the current often indifferent attitude of concerned specialties.
Type B aortic dissection is a complex dynamic disease with true and false lumens, rentry sites and malperfusion syndromes affecting multiple organs. Selected complicated cases with malperfusion syndromes are accepted into specialized units for intervention, either open, endovascular or hybrid approaches, however, the majority are managed medically. Managing blood pressure is complex in this setting and on occasions requires high-level care with invasive monitoring including arterial lines and spinal drainage. As thoracic aortic intervention in the UK enters a new era, it is incumbent on us to set standards for best care. Our suggestion is that it is no longer an acceptable standard of care to leave management of patients with acute Type B aortic dissections to nonspecialized units.
We review current relevant guidelines and develop a case for registration and or transfer of all Type B aortic dissections to centres which offer a subspecialized aortic service which is multidisciplinary team (MDT)-led and capable of offering a full range of interventional services whether open surgery, endovascular or a hybrid procedure.
Acute aortic syndrome
Acute aortic dissection is included within a spectrum of disease termed acute aortic syndrome. 5 The syndrome includes diseases from intimal tear, localized/extensive dissection, intramural haematoma, penetrating atherosclerotic ulcer, and injury from trauma. Acute aortic dissection by definition involves an entry tear in the intima and commonly an exit tear and may well be complex with multiple tears and flaps. Figure 1 shows a representation of this disease process as cyclical with initiation and propogation of the injury superimposed on spectrum of chronic disease processes. The representation demonstrates several very interesting aspects in the concept of aortic dissection and its natural history. First, and as suggested by Vilacosta and San Roman, 5 penetrating atherosclerotic ulcer and intramural haematoma may be preludes to full-blown dissection which introduces dilemmas in the management of these entities and predicting their behaviour. Following from this is the second interesting aspect which is that studies have shown reversibility and intramural haematoma may progess to full dissection or even regress. 6 Understanding the regulatory points in this cycle is key to predicting behaviour and treating the condition in a patient-specific manner. 
DECLARATIONS

Competing interests
None declared
ESSAY
In contradiction to management of acute Type A aortic dissection which has a mortality of 50% over the first week when managed medically versus 30% when managed surgically, acute Type B dissection has a higher mortality when managed operatively (30%) compared to medical management (10%). 1 More recently the concept of endovascular intervention with fenestration and/or stenting has been reported and is of noticeable success in complicated cases with end-organ compromise. 7 The role of endovascular therapies in modifying the natural history of uncomplicated acute type B dissection remains uncertain. A recent trial (INSTEAD) has shown no additional benefit to this approach in simple uncomplicated acute Type B dissection. 8 The natural history and management of these conditions are further complicated by the frequent presence of aneurismal disease and connective tissue disorders. Given the dynamic and often unpredictable natural history of these conditions, there requires a strong element of multidisciplinary experience as well as capacity for monitoring end-organ perfusion, repeat scanning and multimodality therapy to achieve a successful outcome. The exact form of intervention in these different maladies is reviewed in several publications but is best summarized in the American Heart Association Guidelines 3 and is beyond the scope of this essay which concentrates on organization of services.
UK national and international outcomes
We have no good data on the national incidence of acute Type B aortic dissection in the UK. Neither do we know how many of these patients are treated medically or how many undergo surgery or endovascular treatment. We do not know the immediate survival or long-term outcomes for this disease in the UK. The regulatory societies of relevant specialties (Society of Cardiothoracic Surgery [SCTS; see www.scts.org.uk], British Vascular Society [BVS; see www.vascularsociety.org.uk], British Society Interventional Radiology [BSET; see www.bsir.org.uk]) and commercial companies each hold some information on patients who receive intervention; however, they do not give us a reliable or comprehensive picture. The best data available come from the UK Government Office of National Statistics (see www.statistics.gov.uk) on causes of death in England and Wales (ICD-10, 171). We have extracted data from the 'DIY analysis'. For 2007 there are data suggesting overall there were 8160 (4896 men, 3264 women) deaths from 'aortic aneurysm and dissection'. This is further divided into 'dissection of aorta (any part) (171.0)' constituting 1639 deaths (757 men, 882 women). Presumably, this figure of 1639 represents the number of annual deaths from aortic dissections (Type A or B), acute or chronic, admitted or not. Another source of information is Hospital Episode Statistics (see www.hesonline.nhs.uk) data suggesting there were a total of 1195 'admissions' with a diagnosis 'dissection of aorta (any part)' in the year 2004-2005. Of these, 552 (344 men, 208 women) were 'emergency admissions', and presumably most represent acute Type A or Type B diagnoses. The non-emergency admissions may represent elective management of chronic dissections. Using SCTS data, we can determine there were approximately 1200 patients admitted and operated on for Type A dissection during the period 2004-2008, approximately 300 per year. As a rough guide we can calculate there may be in the region of 300 patients admitted annually with acute Type B aortic dissection. While these are useful data that point us to the annual caseload of acute Type B aortic dissection in the UK, it does not tell us about the short-and long-term outcomes for our patients. Given a population of 55 million in the UK we might expect an annual incidence of around 550 which is very similar to that suggested by Office of National Statistics data quoted above.
Our first suggestion in this essay is that we systematically collect data on admissions and outcomes for dissection of the aorta both Type B and Type A. Voluntary registers are rarely comprehensive, accurate or maintained over the long term. We suggest a simple approach would be to campaign for ICD codes to make the simple distinction between Type A and Type B making it easy to identify patients, cross-check with their HES data and survival rates using the national tracking service.
Existing service arrangements: who and where?
Current service provision is mixed at best. Acute Type A aortic dissection is transferred to Cardiac Surgery Units for immediate surgery. Type B aortic dissection in the acute phase may either be managed medically in non-specialized units or, if complicated, transferred to either Cardiac Surgery, Vascular Surgery, Cardiology or Interventional Radiology. Long-term follow-up of Type B aortic dissection is equally variable depending on local arrangements. We suggest there needs to be some compulsory service arrangements to oversee this process. While we acknowledge local service arrangements will always prevail since it reflects historical service development, specialization and interest, we suggest the process should be overseen by a MDT ensuring registration of cases, patient-specific intervention and audit of process and outcomes. We suggest this oversight should be enshrined in National Institute for Health and Clinical Excellence (NICE) guidelines or European guidelines on managing aortic dissection. Retrospective discussion of acute Type A dissection and 'rolling discussion' of acute Type B dissection should be mandatory.
What do UK governing bodies say about service provision of acute Type B?
NICE guidelines
NICE guidelines exist entitled Endovascular stentgraft placement in thoracic aortic aneurysms and dissections (Guidance 127) (see www.nice.org.uk). Although not comprehensive, or specifically associated with dissection only, they relate generally to a specific treatment modality used on occasions in this disease. The guidance is simple and states: '(1) Current evidence on the safety and efficacy of endovascular stent-graft placement in thoracic aortic aneurysms and dissections indicates that it is a suitable alternative to surgery in appropriately selected patients, provided that the normal arrangements are in place for consent, audit and clinical governance; (2) Clinicians should enter all patients having endovascular stent-graft placement in thoracic aortic aneurysms and dissections into the thoracic stent-graft registry supported by the Vascular Society of Great Britain and Ireland and the British Society of Interventional Radiology; (3) The procedure should be performed by a multidisciplinary team with access to facilities for cardiothoracic surgery and cardiopulmonary bypass.'
The merits of open versus endovascular treatments of these conditions is beyond the scope of this manuscript, however, several important aspects of care are stipulated. First, whatever procedure is performed, it should be MDT-led. Second, if endovascular intervention is indicated it should be performed in a facility with provision for on-site conversion to an open procedure with cardiopulmonary bypass. Last, processes should be in place for consent, audit and clinical governance. Consent implies an appropriate specialist should see the patient to have a full discussion about all options either open, endovascular or hybrid. Audit and clinical governance implies a facility for registration of activity and outcomes.
The UK Department of Health 'Service Framework for Cardiovascular Health and Well Being'
The national service framework covering vascular diseases has been published by the UK government Department of Health (see www.nimast.org.uk). Standard 36 discusses patients presenting with features of thoracic aortic dissection. The headline statement is 'all patients presenting with features of thoracic aortic dissection should be assessed and referred immediately to an appropriate management centre'. It is suggested an appropriate centre for proximal aorta in a cardiology/cardiothoracic surgical centre, while distal aorta, arch and descending aorta this should be a regional vascular unit. Essentially the document recommends CT and echocardiography as the gold standard investigation with the mainstay of initial medical therapy as control of blood pressure. Although the boundaries between Type A and Type B are often blurred, the document recommends observation and assessment in a coronary care or high-dependency unit. Not surprisingly, Type A dissection requires surgery while endovascular intervention is an option for complicated Type B -something discussed elsewhere. Interestingly, performance indicators are set as percentage of patients referred to an appropriate centre within 24 hours of symptoms. Although no baseline data are described, the document suggests there should be a 35% increase in this performance indicator by 2012.
Points of interest in this document include performance indicators. In order to improve performance there must be audit processes in place. While this document divides intervention between specialties based on anatomy, we suggest this is divisive and stipulates a general preference for endovascular or hybrid solutions to the arch and descending thoracic aorta. We suggest the process should be patient-specific and based on the anatomy of the pathology and patient co-morbdities and, therefore, should be MDT-led not 'intervention-led'.
The Vascular Society of Great Britain and Ireland
The Vascular Society published The Provision of Service for Patients with Vascular Disease in 2009 (see www.vascularsociety.org.uk). The document is a detailed record of routine vascular work but has a few important comments on thoracic aortic disease suggesting treatment is complex and highly-skilled interventions should be undertaken in centres with the expertise and a commitment to provide a centralized service for these patients. No specific mention of thoracic aortic dissection is made. An important statement in this document relates to working arrangement of specialists suggesting 'time should be available in the working week, and recorded as direct clinical care on Job Plans to develop MDT for clinical problems requiring the input of other specialist service (e.g. stroke care, renal access, thoracic aneurysms)' (5.12 ). In addition, Section 5.14 states 'all care (medical, open surgical and endovascular) should be managed through the local MDT'. Section 5.38 refers directly to the relationship between vascular and cardiac surgery stating that collaborative surgery is increasingly being undertaken for patients with thoraco-abdominal aneurysms.
An encouraging theme running through this document is the support for the MDT as a conduit through which all activity should be entered.
Radiology as described above. The SCTS has no specific recommendations on intervention and management of Type B aortic dissection.
What information on service provision can we extract from international studies and guidelines?
The American Heart Association
The newly published AHA guidelines 3 on thoracic aortic disease has a specific section referring to service delivery in Section 17.1 entitled 'Recommendations for Quality Assessment and Improvement for Thoracic Aortic Disease (AHA Guidelines)'. Although not specifically for Type B aortic dissection they remain broadly relevant. Class I recommendations with Level C evidence state:
'(1) Hospitals that provide regional care for patients with acute sequelae of thoracic aortic disease (e.g. procedures for thoracic aortic dissection and rupture) should participate in standard quality assessment and improvement activities, including thoracic aortic disease registries. Such activities should include periodic measurement and regional/national interfacility comparisons of thoracic aortic disease-related procedural volumes, complications and risk-adjusted mortality rates; (2) Hospitals that provide regional care for patients with acute sequelae of thoracic aortic disease (e.g. procedures for thoracic aortic dissection and rupture) should facilitate and coordinate standardized quality assessment and improvement activities with transferring facilities and emergency medical service teams.
(i) Cooperative joint facility meetings to discuss opportunities for quality improvement; and (ii) Interfacility and emergency medical services team comparisons of pretransfer care based on available outcome data and future performance measures developed in accordance with guidelines.'
Suggested domains of quality include procedural volumes (facility and operator), outcomes (risk adjusted mortality, readmissions or complications), time to diagnosis and intervention and structural measures (distance to nearest referral centre, services available and contingency planning).
These recommendations are pivotal in defining a mechanism for ensuring quality of services relevant to this area of medicine and argue in favour of the suggested service organization suggested here.
The International Registry of Aortic Dissection?
The IRAD franchise collect and publish data on aortic dissection but have offered no suggestions for service provision (see www.iradonline.org).
The European Society of Cardiology (ESC)?
The ESC has issued very detailed guidelines on diagnosis and management of aortic dissection but offer no advice on service provision. 4
The Cochrane Library?
The Cochrane Collaboration has published a metaanalysis in this area but it specifically attempts a comparison between TEVAR and open surgery for thoracic aortic aneurysm (see www.cochrane.org). Suffice to say there are no conclusions. There are no statements on service provision.
A 'hub and spoke' model for care of aortic dissection in Minnisota
A recent paper published in Circulation (Cardiovascular Quality and Outcomes) describes an interesting MDT-based model for regional care of aortic emergencies. 9 Based in Minneapolis, the tertiary specialist centre has set up a programme of regionwide education and protocols to increase awareness, diagnosis and improve early management and transfer to specialist services. This approach has had a dramatic effect on time to intervention and outcomes for these patients.
Proposal for UK and implementation
Acute aortic syndrome is a complex dynamic disease whose natural history can be managed with Multidisciplinary team-led management of acute Type B aortic dissection in the United Kingdom? favourable outcomes providing the patient is able to access the appropriate specialist facilities in a timely manner. A recent meeting of the SCTS (Liverpool 2010) has highlighted the need for centralization of aortic dissection services (Type A) to a few centres within the UK with the intent of improving outcomes. Ideally we suggest this should be extended to Type B dissection. Simple and complicated Type B dissections should all be referred to specialized centres for consultation. All cases should be registered and discussed at a thoracic aortic MDT. Advice should be issued and arrangements made for follow-up care. Complicated Type B dissections should be transferred to specialized units and admitted to intensive case for treatment by an MDT involving cardiac surgeons, vascular surgeons, interventional radiologists and intensivists. All treatment modalities should be available. Centres with the capacity and the interest should be encouraged to transfer all Type B dissection. (simple or complicated) for centralized specialized care. Attempts should be made to create local area networks to improve the efficiencies and outcomes of the service. Follow-up specialized services should be available and there should be audit and good clinical governance. We suggest NICE Guidelines, as well as supporting statements from national and European societies should mandate true prospective and retrospective MDT discussion. Recognition of regional networks treating these patients, by the UK Government Care Quality Commission, should in a part be based on evidence of this multidisciplinary process and, of course, outcomes.
